Suppr超能文献

咖啡和茶的摄入量与胶质瘤风险:队列研究的荟萃分析

Coffee and tea consumption and glioma risk: a meta-analysis of cohort studies.

作者信息

Pan Jinyu, Shao Chuan, Tang Hui, Wu Nan

机构信息

Department of Neurosurgery, Chongqing General Hospital, Chongqing University, Chongqing, China.

Department of Neurosurgery, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, China.

出版信息

Front Nutr. 2024 Dec 16;11:1506847. doi: 10.3389/fnut.2024.1506847. eCollection 2024.

Abstract

BACKGROUND

Research on the association between glioma risk and coffee and tea consumption remains inconclusive. This study seeks to present a meta-analysis of the relationship between coffee and tea intake and glioma risk.

METHOD

Relevant cohort studies that collected coffee and tea exposure prospectively were identified through searches of the PubMed, Embase, and Scopus databases. Eligible studies included those providing adjusted relative risk estimates or hazard ratios (HRs) with 95% confidence intervals (CIs), or data sufficient for such calculations. Study quality was evaluated using the Newcastle-Ottawa Scale, while the GRADE system assessed the quality of evidence. The analysis explored glioma risk concerning the highest versus lowest levels of coffee and tea intake, supplemented by a dose-response evaluation using a one-stage robust error meta-regression model.

RESULTS

A total of nine studies, published between 2004 and 2020, were included. In a model comparing the highest and lowest levels of coffee and tea consumption, 3,896 glioma cases were identified among 2,648,468 participants. Correspondingly, the pooled HRs with 95% CIs were 0.98 (0.87-1.09) for coffee and 0.95 (0.86-1.06) for tea, respectively. Furthermore, no evidence of publication bias was detected for either beverage. The dose-response analysis indicated a near "L"-shaped relationship between tea consumption and glioma risk, with the most notable risk reduction observed in individuals consuming more than 2.5 cups of tea per day. However, additional tea intake beyond this threshold did not confer evident risk reduction. According to Grade scoring system, the quality of meta-evidence was classified as "very low" for coffee and "low" for tea.

CONCLUSION

This meta-analysis provides evidence suggesting a potential inverse association between tea consumption and glioma risk, while no such association was observed for coffee consumption. Given that the evidence for coffee was classified as "very low" and for tea as "low," cautious interpretation of the findings is warranted, and further research is needed to validate these results.

摘要

背景

关于胶质瘤风险与咖啡和茶摄入量之间关联的研究尚无定论。本研究旨在对咖啡和茶的摄入量与胶质瘤风险之间的关系进行荟萃分析。

方法

通过检索PubMed、Embase和Scopus数据库,确定前瞻性收集咖啡和茶暴露情况的相关队列研究。符合条件的研究包括那些提供调整后的相对风险估计值或风险比(HRs)及95%置信区间(CIs),或有足够数据进行此类计算的研究。使用纽卡斯尔-渥太华量表评估研究质量,同时采用GRADE系统评估证据质量。分析探讨了与咖啡和茶摄入量最高水平与最低水平相关的胶质瘤风险,并使用单阶段稳健误差元回归模型进行剂量反应评估作为补充。

结果

共纳入2004年至2020年间发表的9项研究。在比较咖啡和茶消费最高水平与最低水平的模型中,2,648,468名参与者中识别出3,896例胶质瘤病例。相应地,咖啡的合并HRs及95% CIs为0.98(0.87 - 1.09),茶为0.95(0.86 - 1.06)。此外,两种饮品均未检测到发表偏倚的证据。剂量反应分析表明,茶的消费与胶质瘤风险之间呈近似“L”形关系,每天饮用超过2.5杯茶的个体风险降低最为显著。然而,超过此阈值的额外茶摄入量并未带来明显的风险降低。根据Grade评分系统,咖啡的元证据质量被分类为“非常低”,茶为“低”。

结论

这项荟萃分析提供的证据表明,茶的消费与胶质瘤风险之间可能存在负相关,而咖啡消费未观察到此类关联。鉴于咖啡的证据被分类为“非常低”,茶为“低”,对研究结果需谨慎解读,需要进一步研究来验证这些结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d0/11684387/880c8bf4e30b/fnut-11-1506847-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验